Pro Dex (PDEX) risk factors, FY2024 10-K

Pro Dex's FY2024 10-K, filed Sep 05, 2024, lists 22 risk factors in 4 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
224 groups
Section length
5k wordsItem 1A

Pro Dex's biggest risks in the FY2024 10-K

  • Concentration risk is extremely high, with the top three customers generating 88% of fiscal 2024 sales.
  • Internal control weaknesses in inventory accounting and investment valuation persist.
  • Operations depend heavily on medical device sales and a single financial institution for cash.

The risks most specific to Pro Dex

  • Risks Related to Our Business and the Industry in Which We Operate

    A substantial portion of our revenue is derived from a few customers. If we were to lose a key customer, it would have a material adverse effect on our business, financial condition, and results of operations

    In fiscal 2024, our top three customers generated 88% of sales and our largest customer accounted for 71% of sales.

  • Risks Related to Our Business and the Industry in Which We Operate

    A substantial portion of our business is derived from our core business area that, if not serviced properly, may result in a material adverse impact upon our business, financial condition, and results of operations

    In fiscal 2024, medical device products and services provided 99% of our total revenue.

  • Risks Related to Our Business and the Industry in Which We Operate

    In recent years, we have launched several new medical device products and our estimates of warranty claims are based largely on our previous history from similar legacy products. If actual warranty claims exceed our estimates, it could have an adverse effect on our results of operations and financial condition

    Actual warranty claims on new CMF and thoracic surgical devices could exceed our estimates based on legacy products.

  • Risks Related to Our Business and the Industry in Which We Operate

    Our cash and cash equivalents may be exposed to banking institution risk

    All cash balances are held with a single financial institution, exposing us to potential bank failure risks like the SVB collapse.

  • Regulatory & Compliance Risks

    Our operations are subject to a number of complex government regulations, the violation of which could have a material adverse effect on our business

    Medical device manufacturing and distribution are heavily regulated by federal and state agencies including the FDA and EPA.

  • Regulatory & Compliance Risks

    We have identified material weaknesses in our internal control over financial reporting. Failure to achieve and maintain effective internal control over financial reporting could materially and adversely affect our business, results of operations, financial condition, and stock price

    We identified material weaknesses in internal control over financial reporting for inventory accounting and Level 2 and Level 3 investment valuations.

All 22 risk factors

Headings as the filing states them, in filing order.

Risks Related to Our Business and the Industry in Which We Operate

  1. 01A substantial portion of our revenue is derived from a few customers. If we were to lose a key customer, it would have a material adverse effect on our business, financial condition, and results of operations
  2. 02A substantial portion of our business is derived from our core business area that, if not serviced properly, may result in a material adverse impact upon our business, financial condition, and results of operations
  3. 03Our customers may cancel or reduce their orders, change production quantities, or delay production, any of which would reduce our sales and adversely affect our results of operations
  4. 04In recent years, we have launched several new medical device products and our estimates of warranty claims are based largely on our previous history from similar legacy products. If actual warranty claims exceed our estimates, it could have an adverse effect on our results of operations and financial condition
  5. 05We face significant competition from a number of different sources, which could negatively impact our results of operations
  6. 06The industry in which we operate is subject to significant technological change and any failure or delay in addressing such change could adversely affect our competitive position or could make our current products obsolete
  7. 07We rely heavily on our proprietary technology, which, if not properly protected or if deemed invalid, could have a material adverse effect on our business, financial condition, and results of operations
  8. 08If our technology infrastructure is compromised, damaged or interrupted by a cybersecurity incident, data security breach or other security problems, our results of operations and financial condition could be adversely affected
  9. 09Our ability to make payments on, and to refinance, our debt obligations and to fund capital expenditures, will depend on our ability to generate cash in the future, which, in turn, is subject to general economic, financial, competitive, regulatory and other factors, many of which are beyond our control
  10. 10Our cash and cash equivalents may be exposed to banking institution risk
  11. 11Our operations are dependent upon our key personnel. If such personnel were to leave unexpectedly, we may not be able to execute our business plan
  12. 12We may not be able to successfully integrate our business acquisitions, which could adversely affect our business, financial condition, and results of operations
  13. 13We have experienced operating losses in the past. Our ability to achieve or sustain profitability is based on a number of factors, many of which are out of our control, including the material costs for our products and the demand for our products

Risks Related to Ownership of Our Common Stock

  1. 14Our quarterly results can fluctuate significantly from quarter to quarter, which may negatively impact the price of our shares and/or cause significant variances in the prices at which our shares trade

Regulatory & Compliance Risks

  1. 15Our operations are subject to a number of complex government regulations, the violation of which could have a material adverse effect on our business
  2. 16We continually face the possibility of litigation as either a plaintiff or a defendant. It is not reasonably possible to estimate the awards or damages, or the range of awards or damages, if any, that we might incur in connection with such litigation
  3. 17The agreements governing our various debt obligations impose restrictions on our business and could adversely affect our ability to undertake certain corporate actions
  4. 18The agreements governing our debt obligations also require us to comply with a number of financial ratios, borrowing base requirements and additional covenants
  5. 19We are subject to changes in and interpretations of financial accounting matters that govern the measurement of our performance, compliance with which could be costly and time-consuming
  6. 20We have identified material weaknesses in our internal control over financial reporting. Failure to achieve and maintain effective internal control over financial reporting could materially and adversely affect our business, results of operations, financial condition, and stock price
  7. 21Our evaluation of internal controls and remediation of potential problems is costly and time-consuming and could expose weaknesses in financial reporting

General Risks

  1. 22The global economic environment may impact our business, financial condition, and results of operations

Other Pro Dex 10-Ks

  • FY2026 10-K risk factors
    22 risks1 new2 dropped2 reworded

    APM acquisition adds exposure to ITAR, EAR, sanctions, and U.S. government-contracting requirements.

    Filed Sep 03, 2026
  • FY2025 10-K risk factors
    23 risks1 new3 reworded

    Customer concentration intensified, with the top three customers rising to 94% of sales and the largest customer reaching 75%.

    Filed Sep 04, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.